Page last updated: 2024-08-16

scriptaid and isocombretastatin a-4

scriptaid has been researched along with isocombretastatin a-4 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Al-Mouhammad, H; Alami, M; Bauvais, C; Benihoud, K; Bignon, J; Bollot, G; Borgel, D; Dubois, J; Feuillard, J; Hamze, A; Jayat-Vignoles, C; Kasselouri, A; Lamaa, D; Levaique, H; Lin, HP; Ouaissi, M; Pamlard, O; Saller, F; Souce, M; Zig, L1
Alami, M; Apcher, S; Askenatzis, L; Balcerowiak, C; Baschieri, F; Bauvais, C; Bignon, J; Blanchard, V; Bollot, G; Deroussent, A; Ducellier, S; Hamze, A; Hauguel, C; Ibrahim, N; Lafanechère, L; Laisne, MC; Lamaa, D; Letribot, B; Levaique, H; Michallet, S; Montagnac, G; Nascimento, M; Papot, S; Prost, B; Provot, O; Renko, D; Tran, C1

Other Studies

2 other study(ies) available for scriptaid and isocombretastatin a-4

ArticleYear
Design and Synthesis of Tubulin and Histone Deacetylase Inhibitor Based on iso-Combretastatin A-4.
    Journal of medicinal chemistry, 2018, Aug-09, Volume: 61, Issue:15

    Topics: Antineoplastic Agents; Cell Proliferation; Chemistry Techniques, Synthetic; Drug Design; HCT116 Cells; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; K562 Cells; Protein Conformation; Stilbenes; Tubulin

2018
Design, synthesis and biological evaluation of quinoline-2-carbonitrile-based hydroxamic acids as dual tubulin polymerization and histone deacetylases inhibitors.
    European journal of medicinal chemistry, 2022, Oct-05, Volume: 240

    Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Drug Design; Drug Screening Assays, Antitumor; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Hydroxamic Acids; Polymerization; Quinolines; Repressor Proteins; Tubulin

2022